EU inches closer to new pharma legislation amid competitiveness drive
Pharmaceutical companies marketing products in Europe could be set for a commercial boost, after legislators have agreed on a new…
News
China’s NMPA approves Sanofi’s rare haematologic disease treatments
Zealand Pharma and OTR to develop metabolic disease therapeutics
Novartis and UK-based Relation forge R&D deal worth up to $1.7bn
Moderna signs deal worth up to $503m with Nanexa
UK slashes 2026 drug rebate rate by one-third to win back pharma sentiments
Pfizer plans job cuts in Switzerland to reduce expenses
Boehringer’s Jascayd gains China’s NMPA approval for PPF
